 Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 1999 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 4 | 1 | 5 | | 2002 | 3 | 1 | 4 | | 2003 | 9 | 1 | 10 | | 2004 | 9 | 2 | 11 | | 2005 | 6 | 3 | 9 | | 2006 | 7 | 4 | 11 | | 2007 | 6 | 2 | 8 | | 2008 | 5 | 1 | 6 | | 2009 | 7 | 5 | 12 | | 2010 | 4 | 2 | 6 | | 2011 | 7 | 3 | 10 | | 2012 | 9 | 6 | 15 | | 2013 | 4 | 3 | 7 | | 2014 | 9 | 2 | 11 | | 2015 | 11 | 1 | 12 | | 2016 | 13 | 4 | 17 | | 2017 | 10 | 3 | 13 | | 2018 | 1 | 2 | 3 | | 2019 | 11 | 1 | 12 | | 2020 | 7 | 2 | 9 | | 2021 | 8 | 0 | 8 | | 2022 | 4 | 0 | 4 | | 2023 | 12 | 0 | 12 | | 2024 | 6 | 2 | 8 | | 2025 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Krausser L, Van Dyck-Lippens M, Balde R, Reenaers R, Al Mubarak R, Rigouts L, Walter ND, Voskuil MI, Van Rie A, de Jong BC, Braet SM. 70% ethanol preserves mycobacterial RNA from cultures more efficiently than GTC-TCEP. Sci Rep. 2025 Apr 10; 15(1):12322.
-
Singh M, Sarhan MO, Damiba NNL, Singh AK, Villabona-Rueda A, Nino-Meza OJ, Chen X, Masias-Leon Y, Ruiz-Gonzalez CE, Ordonez AA, D'Alessio FR, Aboagye EO, Carroll LS, Jain SK. Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis. Nat Commun. 2025 Mar 27; 16(1):3003.
-
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Ektnitphong V, Bauman AA, Massoudi LM, Voskuil MI, Robertson GT, Moore CM, Walter ND. Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice. Antimicrob Agents Chemother. 2025 Feb 13; 69(2):e0131024.
-
Lyu J, Narum DE, Baldwin SL, Larsen SE, Bai X, Griffith DE, Dartois V, Naidoo T, Steyn AJC, Coler RN, Chan ED. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol. 2024; 15:1427559.
-
Gap-Gaupool B, Glenn SM, Milburn E, Turapov O, Crosatti M, Hincks J, Stewart B, Bacon J, Kendall SL, Voskuil MI, Riabova O, Monakhova N, Green J, Waddell SJ, Makarov VA, Mukamolova GV. Nitric oxide induces the distinct invisibility phenotype of Mycobacterium tuberculosis. Commun Biol. 2024 Sep 28; 7(1):1206.
-
Rogers I, Barron MA. Evaluating the role of Mycobacterium tuberculosis PCR in ruling out active tuberculosis. Am J Infect Control. 2024 Nov; 52(11):1339-1341.
-
Gutka HJ, Bondoc JMG, Patwell R, Khan S, Grzelak EM, Goswami R, Voskuil MI, Movahedzadeh F. Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy. PLoS One. 2024; 19(6):e0304876.
-
Cele N, Awolade P, Seboletswe P, Khubone L, Olofinsan K, Islam MS, Jordaan A, Warner DF, Singh P. Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline-pyrazolopyrimidine hybrids and Quinoline-4-Arylamines. ChemistryOpen. 2024 Sep; 13(9):e202400014.
-
Xia J, Palestine AG, Reddy AK. Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region. Am J Ophthalmol. 2024 08; 264:1-7.
-
Lyons MA, Obregon-Henao A, Ramey ME, Bauman AA, Pauly S, Rossmassler K, Reid J, Karger B, Walter ND, Robertson GT. Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis. Antimicrob Agents Chemother. 2024 05 02; 68(5):e0101023.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|